ArticleAmerican journal of translational research2025
Comprehensive evaluation and clinical implications of kernel extreme learning machine long short term memory transformer framework.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo develop and validate a hybrid deep learning model to enhance diagnostic and predictive accuracy of Alzheimer's disease (AD) using readily available clinical data.
methodsA triple-architecture joint model was constructed, integrating a Kernel Extreme Learning Machine (KELM), a Long Short-Term Memory (LSTM) network, and a Transformer. This framework was designed to capture nonlinear associations, temporal dynamics, and global feature dependencies. The model was trained and validated on 2,149 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database and externally tested on an independent cohort of 1,012 subjects.
resultsIn internal validation, the model achieved state-of-the-art performance with 95.42% accuracy, 95.63% recall, and an area under the curve (AUC) of 0.981. It also demonstrated strong generalizability in the external cohort, achieving 93.81% accuracy and an AUC of 97.25%. In a longitudinal sub-analysis, the model accurately predicted the 3-year conversion from mild cognitive impairment to AD with 92.78% accuracy. Ablation analyses confirmed the essential contribution of each model component.
conclusionsThe proposed KELM-LSTM-Transformer model provides a powerful and robust framework for AD prediction. Its high accuracy and strong generalizability suggest potential as an effective and accessible tool for early risk stratification, supporting timely clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.